Latest technology news and innovations
Proposed Medicare fee schedule changes may incentivize doctors to provide more support for smoking cessation, increasing reimbursements for counseling services.
GSK has ceased its efforts to develop a chronic cough therapy, citing the challenges faced during clinical trials.
Drug shortages in the U.S. have surged to 227, while GSK halts development of its chronic cough treatment after disappointing trial results.
The recent U.S. policy on testosterone screenings highlights disparities in access to hormone therapy, notably affecting LGBTQ+ individuals.
Sonothera's ultrasound technology promises treatments for Duchenne muscular dystrophy, but experts remain skeptical amid a lack of clinical data.
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.
MDCalc is enhancing trust in clinical decision-making by implementing a new quality-rating system for its calculators, impacting how physicians use these tools.
MAHA's recent initiatives signal a pivotal shift in the dialogue around mental health care, emphasizing deprescribing while sidelining concrete solutions.
Sales under the U.S. drug discount program reached $100 billion in 2025, driven largely by high-cost medications.
HCA Healthcare projects a significant profit drop due to a surge in uninsured patients after subsidy changes under the Affordable Care Act.
Anthropic's Claude Science software targets biopharma research, showcasing AI's positive potential amidst ongoing public skepticism.
The ex-Akero Therapeutics team has formed Avere Therapeutics, targeting immunology with an oral IL-23 inhibitor from a Chinese source.
Health workers in the DRC protest unpaid wages as Ebola cases rise, highlighting the urgent need for coordinated global health responses.
This week's biotech podcast discusses rising health insurance costs and the whistleblower case against an insurer, alongside industry developments.
A significant cyclospora outbreak in Michigan has exceeded 1,000 cases, prompting investigations across several states as health officials seek the source.
The sharp rise in ACA marketplace premium costs significantly affects small businesses, raising new challenges in employee health benefits.
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.